Policy / Pricing Trump backs psychedelics for mental health in new executive order Pharmaceutical TechnologyTrump's executive order sets out to speed up the review of psychedelics, while supporting research into this burgeoning field.Policy / PricingNeuroscienceRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) Pharmaceutical Technology Trump’s executive order sets out to speed up the review of psychedelics, while supporting research into this burgeoning field. Policy / PricingNeuroscienceRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UCB to purchase Neurona and NRTX-1001 for $1.15bnNext: AZ is three for three with COPD hope tozorakimab Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
